sábado, 15 de febrero de 2025

FDA approves vimseltinib for symptomatic tenosynovial giant cell tumor

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-vimseltinib-symptomatic-tenosynovial-giant-cell-tumor

No hay comentarios:

Publicar un comentario